The Direct and Indirect Costs to Society of Carpal Tunnel Release
- PMID: 30417688
- PMCID: PMC7076612
- DOI: 10.1177/1558944718810855
The Direct and Indirect Costs to Society of Carpal Tunnel Release
Abstract
Background: Carpal tunnel syndrome (CTS) is one of the most common compressive neuropathies and affects a large amount of individuals. We investigated the direct and indirect cost to society of operative versus nonoperative management of CTS. Methods: A Monte Carlo simulation model was used to estimate the lifetime direct and indirect costs associated with nonoperative and operative treatment of CTS, and its utility to patients. Results: Operative treatment of CTS had a lower total cost and a higher utility when compared with nonoperative treatment. Conclusions: CTS surgery is clearly a cost-effective treatment strategy that should be included in the societal perspective regarding evolving costs and savings associated with health care.
Keywords: Monte Carlo simulation; carpal tunnel release; carpal tunnel syndrome; cost-effective; health care; patient care; patient utility.
Conflict of interest statement
Figures
References
-
- Atroshi I, Englund M, Turkiewicz A, et al. Incidence of physician-diagnosed carpal tunnel syndrome in the general population. Arch Intern Med. 2011;171(10):943-944. - PubMed
-
- Atroshi I, Gummesson C, Johnsson R, et al. Prevalence of carpal tunnel syndrome in a general population. JAMA. 1999;282(2):153-158. - PubMed
-
- Fajardo M, Kim SH, Szabo RM. Incidence of carpal tunnel release: trends and implications within the United States ambulatory care setting. J Hand Surg Am. 2012;37(8):1599-1605. - PubMed
-
- Foley M, Silverstein B, Polissar N. The economic burden of carpal tunnel syndrome: long-term earnings of CTS claimants in Washington State. Am J Ind Med. 2007;50(3):155-172. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials